Bausch + Lomb (BLCO) P/E (2022 - 2026)
Bausch + Lomb (BLCO) P/E from May 6, 2022 to Jul 21, 2026. The TTM Bausch + Lomb (BLCO) P/E is -25.89. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Bausch + Lomb (BLCO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -25.89 | +54.30% |
| 2025 | -16.78 | -16.24% |
| 2024 | -20.03 | -30.65% |
| 2023 | -28.89 | -130.86% |
| 2022 | 93.59 | N/A |
Comparison Bausch + Lomb (BLCO) P/E with competitors
Bausch + Lomb (BLCO) P/E is -25.89.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -100.86% |
| EMBC | Embecta Corp | 1.69 | -106.53% |
| SOLV | Solventum Corp | 9.49 | -136.67% |
| ZJYL | Jin Medical International Ltd | 12.75 | -149.24% |
| PDEX | Pro-Dex Inc (co) | 15.22 | -158.79% |
| RMD | Resmed Inc | 19.04 | -173.57% |
| UTMD | Utah Medical Products Inc | 20.76 | -180.19% |
| ATR | Aptargroup Inc | 21.65 | -183.62% |
| ALGN | Align Technology Inc | 30.29 | -217.01% |
| HOLX | Hologic Inc | 30.86 | -219.22% |
| MMSI | Merit Medical Systems Inc | 31.15 | -220.31% |
| STVN | Stevanato Group Spa | 31.25 | -220.73% |
| LMAT | Lemaitre Vascular Inc | 36.34 | -240.38% |
| ALC | Alcon Inc | 41.51 | -260.36% |
| ISRG | Intuitive Surgical Inc | 46.43 | -279.34% |
| BDX | Becton Dickinson & Company | 46.93 | -281.29% |
| WST | West Pharmaceutical Services Inc | 47.41 | -283.13% |
| NEPH | Nephros Inc | 50.00 | -293.13% |
| COO | Cooper Companies Inc | 58.98 | -327.82% |
| NNNN | Anbio Biotechnology - Class A | 62.20 | -340.26% |
| NVST | Envista Holdings Corp | 64.66 | -349.78% |
| BAX | Baxter International Inc | 72.66 | -380.66% |
| ICUI | ICU Medical Inc | 84.82 | -427.64% |
| RGEN | Repligen Corp | 162.20 | -726.53% |
| WRBY | Warby Parker Inc - Class A | 318.30 | -1329.52% |